BETHESDA, Md., Sept. 19 /PRNewswire/ -- Sucampo Pharmaceuticals, Inc. today announced that it is a finalist for the 2006 Scrip Award for the best new small-molecule drug category for its new drug Amitiza(TM), a selective chloride channel activator for the treatment of chronic idiopathic constipation in adults.
